Charting the COVID-19 vaccination journey in Saudi Arabia: Insights into post-vaccination adverse effects and immunization dynamics
Our results concluded that Saudi Arabia's vaccination campaign has proven effective, especially after the second and third doses. Pfizer/BioNTech was the most preferred vaccine, demonstrating strong efficacy and safety, which helped build public confidence. Ongoing monitoring is crucial to maintaining pandemic control, post-marketing and public health strategies.
Authors
- Sultan Almuntashiri (ORCID: https://orcid.org/0000-0003-4353-6043)
- Abdulwahab Alamri (ORCID: https://orcid.org/0000-0001-8852-7517)
- Abdulrahman M Alshammari
- Sirajudheen Anwar (ORCID: https://orcid.org/0000-0002-0926-2790)
- Abdulkarim Mohammed Almudayni
- Gehad M. Subaiea (ORCID: https://orcid.org/0000-0001-9212-7786)
- Nawaf Alkhateeb
- Faisal Sahman
- Abdulrahman Alsudayri
- Arshad Hussain
- Hamoud Alrashidi
- Heba Ali Khloofi
Institutions
- University of Ha'il (SA)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-04-28
- DOI
- https://doi.org/10.3389/fphar.2025.1561410
- Citations
- 2
- Primary Topic
- Vaccine Coverage and Hesitancy
- Type
- article
- Field-Weighted Citation Impact
- 4.33
Funders
- University of Hail